India, Sept. 22 -- It is an R&D driven company which deals with research, development and manufacture of active pharmaceutical ingredients, nutritional ingredients, and other specialty products.

The shares of Symbiotec Pharmalab are currently trading at Rs. 1,156.40, Up by 0.13%.The company has a market capitalization of Rs. 7,428.01 crore. The stock's 52 week high is Rs. 1,193.70 and its 52 week low is Rs. 934.20. In the past one month after the ipo it has delivered a return of 5.42%.

What's The News? Symbiotec Pharmalab reported its consolidated financial results for the quarter ended June 30, 2026. The company's consolidated revenue from operations increased 7.4% YoY to Rs. 218.2 crore, compared with Rs. 203.2 crore in Q1 FY26.

Des...